comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 01:58:22 - browse：4

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Prosthetic arm enables patients to feel the objects they grip

hotspot

WSS

NIH chief: government has fallen behind pharma on clinical trials

AI used to predict Covid

AI used to predict Covid

Scientists successfully use ultrasound imaging to map brain activity

What health policies could hitch a ride on a spending bill?

Stigma and the return of syphilis

hotspot

comprehensive

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Study suggests Covid rebound is far more common with Paxlovid than without

Hollywood unions extend contract negotiations for actors

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Childbirth

Walensky prepares to leave CDC — and Congress — behind

Weight loss drugs should be covered by insurers, AMA says

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

First transplant of an entire human eye performed

leisure time

AI used to predict Covid

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

iTeos Therapeutics debuts first data on TIGIT

Carbon Health diabetes program, a test of data

iTeos Therapeutics debuts first data on TIGIT

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

knowledge

hotspot

hotspot

entertainment